Vaxcyte (PCVX) AI Analysis

PCVX$63.37-1.32 -2.04%
BiotechnologyLarge CapGrowth Stock
Compare
Market cap$10.03BEnterprise value$8.29BRevenue (TTM)$0Market positionTop 25%

Score

66
Bullish
Value
57
Quality
40
Growth
100

AI Score 30. Vaxcyte, Inc. has a market cap of $10.34 billion but is in the clinical development stage with no revenue reported, leading to a negative net income margin of 0%

Vaxcyte (PCVX) AI Analysis

PCVX price $63.37 -1.32 -2.04%

Ticker
PCVX
Price
$63.37
Change
-1.32 -2.04%
Market cap
$10.03B
Forward P/E
28.94
Dividend yield
0.00%
Beta
1.29
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
66
Value
57
Quality
40
Growth
100

Stocklytics score rationale: value 57, quality 40, growth 100.

AI Score 30. Vaxcyte, Inc. has a market cap of $10.34 billion but is in the clinical development stage with no revenue reported, leading to a negative net income margin of 0%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener